I found the lectures earlier this month pertaining to enzyme mechanisms really interesting, especially our discussion of the Induced Fit Model. Although I had learned about enzymes before, this deeper exploration of how they “bind to the transition state better than to the substrate” was particularly intriguing. We often learn that enzymes lower the activation energy of a reaction, but understanding how they accomplish this, by stabilizing the substrate in its high-energy configuration, added a new level of complexity to the concepts I’d previously learned. What really caught my attention was learning that ACE inhibitors are designed as transition-state analogues. I found it fascinating to connect this molecular-level design principle to something with such real-world medical importance, especially since my grandmother takes ACE inhibitors daily for high blood pressure. It was insightful to see how this understanding of enzyme chemistry directly translates into effective drug design. In analyzing the ACE active site, I was intrigued by how elegantly it is structured, with precise electrostatic, hydrogen-bonding, and salt-bridge molecular interactions that favor the transition form of the substrate rather than its starting configuration. The idea that subtle molecular mimicry can improve health outcomes made me appreciate just how powerful biochemical insight can be.<\/p>\n","protected":false},"excerpt":{"rendered":"
I found the lectures earlier this month pertaining to enzyme mechanisms really interesting, especially our discussion of the Induced Fit Model. Although I had learned about enzymes before, this deeper exploration of how they “bind to the transition state better … Continue reading